Is a four-week hormone suspension necessary for thyroid remnant ablation in low and intermediate risk patients? A pilot study with quality-of-life assessment. Braz. J. Radiat. Sci. [Internet]. 20 de diciembre de 2022 [citado 21 de julio de 2025];10(4):1-16. Disponible en: https://www.bjrs.org.br/revista/index.php/REVISTA/article/view/2047